| PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
COPB2 |
COPB2: Coatomer subunit beta' |
1.46 |
Evidence |
O
|
| PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
CHC1 |
RCC1: RCC1-I (Fragment) |
1.457 |
Evidence |
|
| GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
PRG4 |
PRG4, MSF, SZP: Proteoglycan-4 precursor |
1.457 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
1.457 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
1.457 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
1.457 |
Evidence |
|
| MYF6 |
MYF6: Myogenic factor 6 |
RYR1 |
|
1.455 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
1.455 |
Evidence |
|
| DPP4 |
DPP4, ADCP2, CD26: Dipeptidyl peptidase 4 |
CCL11 |
CCL11, SCYA11: Eotaxin precursor |
1.455 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
1.455 |
Evidence |
|
| HRG |
HRG: Histidine-rich glycoprotein precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
1.455 |
Evidence |
|
| AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
1.455 |
Evidence |
|
| CCL22 |
CCL22, A-152E5.1, MDC, SCYA22: Small-inducible cytokine A22 precursor |
OXTR |
OXTR: Oxytocin receptor |
1.455 |
Evidence |
|
| RPS6KA4 |
RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 |
MAPK14 |
MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14 |
1.452 |
Evidence |
|
| RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
1.452 |
Evidence |
|
| CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
1.452 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
SHB |
SHB: SH2 domain-containing adapter protein B |
1.452 |
Evidence |
|
| PAX1 |
IPI00419577 |
AHR |
AHR: Aryl hydrocarbon receptor precursor |
1.452 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CHN2 |
CHN2, ARHGAP3, BCH: Beta-chimaerin |
1.452 |
Evidence |
|
| PPFIA3 |
PPFIA3, KIAA0654: Liprin-alpha-3 |
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
1.452 |
Evidence |
|
| GTF2F1 |
GTF2F1, RAP74: Transcription initiation factor IIF subunit alpha |
PSMD2 |
PSMD2, TRAP2: 26S proteasome non-ATPase regulatory subunit 2 |
1.452 |
Evidence |
|
| RAP2A |
RAP2A: Ras-related protein Rap-2a precursor |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
1.452 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
GTPBP4 |
GTPBP4, CRFG, NOG1: Nucleolar GTP-binding protein 1 |
1.452 |
Evidence |
|
| HAMP |
HAMP, HEPC, UNQ487/PRO1003, LEAP1: Hepcidin precursor |
C6 |
C6: Complement component C6 precursor |
1.452 |
Evidence |
|
| GNB2L1 |
Lung cancer oncogene 7 |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
1.452 |
Evidence |
|